2 Marijuana Companies That Are Looking Beyond Canada

The small-cap weed producer Organigram Holdings Inc (TSX:OGI)(NASDAQ:OGI) has its sights set on Europe.

| More on:
Dots over the earth connecting the world

Image source: Getty Images.

Last year, legalization was all the rage in the marijuana industry. This year, international expansion seems to be the name of the game.

With more and more jurisdictions opening their doors to legal cannabis, there are huge export markets up for grabs. And now, even smaller marijuana companies are getting in on the action.

Historically, the large-cap licensed producers (LPs) like Canopy Growth (TSX:WEED)(NYSE:CGC) and Aurora Cannabis always had an eye on exports. Today, we’re also seeing companies with market caps in the millions starting to set their sights abroad. Legalization was a huge one-time boost for Canadian cannabis growers, but as it fades into the rear-view mirror, the revenue growth it generated will likely decelerate. Going forward, then, cannabis companies that expand internationally will have better growth prospects than their domestic-market-oriented peers.

The following are two marijuana stocks that are beginning to stand out in this regard.

Organigram Holdings

Organigram Holdings (TSX:OGI)(NASDAQ:OGI) is a medium-cap cannabis company that’s worth about $682 million.

It’s one of the most profitable marijuana companies, having posted positive net and operating income in two of the past three years.

Small-cap marijuana companies have always had a bit of an advantage in profitability in that they don’t need to invest as much in huge facilities to reach export markets.

Organigram, however, seems to be moving in a global direction. The company has acquired an international presence by buying two companies: Alpha-Cannabis Germany and Eviana. Both ownership stakes are non-controlling and the deals involved other partners, but Organigram owns a significant amount of both companies. Alpha-Cannabis Germany provides medical cannabis to the German market while Eviana harvests hemp in Serbia.

The company is also investing $15 million in what it calls an “industry-leading” cannabis-infused chocolate product, which it says it will export to other countries.

Canopy Growth

Canopy Growth has long been one of the biggest cannabis exporters in Canada. In 2019, that’s still true, but now the company’s presence is even bigger than it was last year.

In the summer of 2018, when the $5 billion Constellation Brands deal was announced, then-CEO Bruce Linton said that Canopy would use the money to establish a market-leading position in the 11 international markets it operates in. It was an ambitious goal.

So far, there is no data on whether Canopy is the “market leader” in the 11 foreign countries it operated in at the time. What is clear is that it has since opened up a lot of other export markets. According to a January Ottawa Citizen report, Canopy had operations in 15 countries, whether through exports or ownership in local companies. That makes it one of the most international cannabis companies. While the company’s aggressive pursuit of global market share has certainly contributed to its ongoing losses, there’s no doubt that the investments could pay off over the long term — especially if adult-use cannabis legalization takes off in other countries.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands, OrganiGram Holdings, and OrganiGram Holdings.

More on Cannabis Stocks

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

A close up image of Canadian $20 Dollar bills
Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »